Asceneuron SA is a biotechnology company based in Lausanne, Switzerland, specializing in the development of innovative therapies for neurodegenerative diseases. The organization focuses on advancing treatments that target the underlying mechanisms of conditions such as Alzheimer's disease and other related disorders. By leveraging cutting-edge research and technology, Asceneuron aims to improve patient outcomes and enhance the quality of life for those affected by these challenging conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

19 Patents

#19 in Lausanne

#644 in Switzerland

#32,623 in the World

Lausanne, Switzerland

Asceneuron Sa

Forward Citations = 123

11 inventors:

Anna Quattropani (19 out of 58 patents)

Santosh Shripad Kulkarni (19 out of 53 patents)

Awadut Gajendra Giri (17 out of 17 patents)

4. David Malcolm Crowe (4 out of 8 patents)

5. Dawn V Toronto (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Asceneuron Sa. Retrieved from https://idiyas.com/company/asceneuron-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]